Literature DB >> 28655199

Proteins Involved in Endocytosis Are Upregulated by Ageing in the Normal Human Brain: Implications for the Development of Alzheimer's Disease.

Mouhamed Alsaqati1,2, Rhian S Thomas1,3, Emma J Kidd1.   

Abstract

The greatest risk factor for Alzheimer's disease (AD) is advanced age, but the reason for this association remains unclear. Amyloid-β (Aβ) is produced from amyloid precursor protein (APP) primarily after APP is internalized by clathrin-mediated or clathrin-independent endocytosis. Changes in endocytosis in AD have been identified. We hypothesized that endocytic protein expression is altered during ageing, thus influencing the likelihood of developing AD by increasing Aβ production. We explored how levels of endocytic proteins, APP, its metabolites, secretase enzymes, and tau varied with age in cortical brain samples from men of three age ranges (young [20-30], middle aged [45-55], and old [70-90]) with no symptoms of dementia. Aβ40 and Aβ42 were significantly increased in old brains, while APP and secretase expression was unaffected by age. Phosphorylated GSK3β increased significantly with age, a possible precursor for neurofibrillary tangle production, although phosphorylated tau was undetectable. Significant increases in clathrin, dynamin-1, AP180, Rab-5, caveolin-2, and flotillin-2 were seen in old brains. Rab-5 also increased in middle-aged brains prior to changes in Aβ levels. This age-related increase in endocytic protein expression, not described previously, suggests an age-related upregulation of endocytosis which could predispose older individuals to develop AD by increasing APP internalization and Aβ generation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28655199     DOI: 10.1093/gerona/glx135

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  7 in total

1.  High glucose-mediated PICALM and mTORC1 modulate processing of amyloid precursor protein via endosomal abnormalities.

Authors:  Chang Woo Chae; Hyun Jik Lee; Gee Euhn Choi; Young Hyun Jung; Jun Sung Kim; Jae Ryong Lim; Seo Yihl Kim; In Koo Hwang; Je Kyung Seong; Ho Jae Han
Journal:  Br J Pharmacol       Date:  2020-07-14       Impact factor: 8.739

2.  Distinct effect of prenatal and postnatal brain expression across 20 brain disorders and anthropometric social traits: a systematic study of spatiotemporal modularity.

Authors:  Peilin Jia; Astrid M Manuel; Brisa S Fernandes; Yulin Dai; Zhongming Zhao
Journal:  Brief Bioinform       Date:  2021-11-05       Impact factor: 13.994

Review 3.  Alzheimer's Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α.

Authors:  Francisco Sáez-Orellana; Jean-Noël Octave; Nathalie Pierrot
Journal:  Cells       Date:  2020-05-14       Impact factor: 6.600

Review 4.  Neurodegeneration and Neuro-Regeneration-Alzheimer's Disease and Stem Cell Therapy.

Authors:  Verica Vasic; Kathrin Barth; Mirko H H Schmidt
Journal:  Int J Mol Sci       Date:  2019-08-31       Impact factor: 5.923

5.  Genetic effects on longitudinal cognitive decline during the early stages of Alzheimer's disease.

Authors:  Atul Kumar; Maryam Shoai; Sebastian Palmqvist; Erik Stomrud; John Hardy; Niklas Mattsson-Carlgren; Oskar Hansson
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.379

Review 6.  Epigenomic Remodeling in Huntington's Disease-Master or Servant?

Authors:  Geraldine Zimmer-Bensch
Journal:  Epigenomes       Date:  2020-07-31

Review 7.  Role of Clathrin and Dynamin in Clathrin Mediated Endocytosis/Synaptic Vesicle Recycling and Implications in Neurological Diseases.

Authors:  Kate L Prichard; Nicholas S O'Brien; Sari R Murcia; Jennifer R Baker; Adam McCluskey
Journal:  Front Cell Neurosci       Date:  2022-01-18       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.